Automating Global Case Intake: How Reportum® Delivered Up to 70% ROI for a Top-50 Healthcare Company
Managing safety data across multiple markets presents significant operational challenges, particularly when data arrives in different formats, languages, and volumes. For a top-50 holistic healthcare company headquartered in Japan, manual processing and translation activities were creating inefficiencies across global pharmacovigilance operations.
Working in partnership with Qinecsa, the organization implemented Reportum, Qinecsa’s digital adverse event intake and automation platform, to streamline global case intake workflows and improve operational efficiency. The result was a substantial reduction in manual effort and an ROI of up to 70% in key use cases.
The Challenge: Managing Complex Global Safety Data Intake
The client globally markets pharmaceutical and nutraceutical products and receives cases from local affiliates around the world. These cases were submitted through country-specific mailboxes, resulting in a fragmented intake process.
Multiple Formats, Languages, and Workflows
The organization needed to process a wide variety of case formats and languages while managing fluctuating reporting volumes. This created a heavy reliance on manual data entry and translation activities, increasing operational burden and limiting efficiency.
As global reporting requirements continued to grow, the company sought a more scalable approach to safety data intake that could support consistency, efficiency, and quality across markets.
The Qinecsa Approach
Simplifying Safety Data Collection
Qinecsa addressed these challenges through Reportum®, its digital adverse event intake platform designed to support direct reporting from patients, caregivers, and healthcare professionals.
The solution provides an easily accessible self-service reporting experience, helping organisations collect complete and relevant safety information at the point of first interaction.
By guiding users through structured reporting forms, Reportum® helps improve the consistency and quality of information submitted while creating a more intuitive reporting experience.
The Solution
AI-Powered Case Intake Automation with Reportum
Qinecsa worked closely with the client to understand its pharmacovigilance processes and identify the areas where automation could deliver the greatest value. Initial efforts focused on specific case formats and languages with the highest potential return on investment.
Intelligent Document Ingestion and Translation
Using AI and machine learning technology within Reportum, Qinecsa designed and implemented document ingestion capabilities for both client-specific and industry-standard forms. The solution supported English and Japanese documents and automatically ingested more than 120 data fields.
Streamlined End-to-End Workflow
The workflow incorporated:
- Automated document ingestion
- Ingestion review
- Redaction processes
- Translation review
- Export of E2B(R3) files into the client’s safety database
This approach helped create a more efficient and standardized case intake process while maintaining oversight and quality controls.
The Outcome: Reduced Manual Effort and Strong ROI
By introducing automation into key pharmacovigilance workflows, the client significantly reduced the manual effort required to process incoming cases. Deployment of Reportum delivered up to 70% ROI, particularly in workflows requiring both document ingestion and automated translation capabilities.
The solution provided a scalable foundation for managing global case intake while supporting the organization’s broader pharmacovigilance objectives.
"Direct reporting is a critical component of modern pharmacovigilance. By making adverse event reporting simpler and more accessible, Reportum® helps organisations improve data quality, reduce manual effort, and strengthen their overall safety operations."
Impact
Improving Efficiency and Data Quality
By enabling direct digital reporting, Reportum® helps organisations improve the quality and completeness of safety data while reducing operational burden across pharmacovigilance teams.
Benefits include:
- Capture of complete and relevant data at first interaction
- Reduced pressure on safety call centres
- Improved report quality
- Reduced need for follow-up activities
- Elimination of manual reconciliation processes
- Elimination of manual safety database data entry
- Reduced downstream case processing effort
Based on consolidated Qinecsa metrics, organisations using Reportum® have achieved up to a 70% reduction in safety team workload.
Supporting Modern Pharmacovigilance Operations
As pharmacovigilance teams continue to face increasing case volumes and growing regulatory expectations, digital-first adverse event intake can play an important role in improving efficiency, data quality, and reporting accessibility.
Reportum® helps pharmaceutical organisations modernise adverse event collection by enabling direct reporting from patients, caregivers, and healthcare professionals while reducing manual effort across the safety workflow.